Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
BPC-157 and Gabapentin Interaction: What You Need to Know At a glance BPC-157 status / 503A compounded research peptide, not FDA-approved Gabapentin class / alpha-2-delta calcium channel ligand, anticonvulsant Formal interaction studies / none published as of 2025 Primary concern / additive CNS depression (sedation, dizziness) Secondary concern / both agents rely heavily on renal elimination CYP450 involvement / gabapentin: none
Broad range of clinical applications Depending on your clinical profile, a peptide protocol may be designed to address multiple physiological priorities tissue recovery, immune support, hormonal balance, and metabolic function when evidence and your individual assessment support it
The safety, quality, and clinical support behind it do not compare
This disease burden can significantly impair health-related quality of life [2]
US$ 21.75
US$ 25.43
US$ 23.75
US$ 28.72
